Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

(Gain) Loss Derivative Instruments

Accordingly, the Condensed Consolidated Statement of Income includes the impact of Merck’s derivative financial instruments prior to the Separation that is deemed to be associated with the Company’s operations and has been allocated to the Company utilizing a proportional allocation method:

	Three Months Ended September 30,				Nine Months Ended September 30,
($ in millions)	2021		2020		2021		2020
Allocated net (gains) loss in Sales	$	—	$	6	$	(56)	$	(12)
Net (gains) loss in Other (income) expense, net(1)	(3)		82		29		97
Foreign exchange (gains) loss in Other (income) expense, net(1)	4		(64)		(23)		(45)

(1)Includes net gains and losses and foreign exchange gains and losses allocated for the period prior to the Separation, as well as actual net gains and losses and foreign exchange gains and losses post-Separation.